CHARLOTTE – The Charlotte-based software company PeraHealth, Inc., won a contract that will enable the company to support the development and installation of the company’s Rothman Index Risk Triage tool on mobile and desktop applications as an option for hospitals nationwide with a focus on increasing effective triage responses to COVID-19.
The Rothman Index, which was developed by PeraHealth, is a machine learning algorithm that the company says is capable of deriving a real-time acuity score cleared by the U.S. Food and Drug Administration (FDA) within information coded in a patient’s electronic health record. “The patented algorithm calculates a patient’s health score from vital signs, lab results, and the hundreds of factors comprising the full range of body-system nursing assessments,” the company said in a statement regarding its technology.
The cost-sharing contract was awarded by the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response (ASPR) at the U.S. Department of Health and Human Services (HHS) and is one component of the organization’s Rapidly Expanding DRIVe Medical countermeasures portfolio.
“We are grateful for, and thrilled by, BARDA’s support to fund the advancement of the Rothman Index Risk Triage tool to support healthcare professionals during the pandemic. This cost-share contract represents a critical milestone in our organization as we pivot to support patient triage in the emergency department for our hospital partners,” said Greg White, PeraHealth CEO. “Emergency department capacities have experienced historic highs in the last 12 months, so developing effective clinical decision support countermeasures is essential.”
